This is a regulatory disclosure made to the BSE and NSE pursuant to Regulation 30 and Para A of Part A of Schedule III of the SEBI (LODR) Regulations, 2015. The purpose is to inform the exchanges of the company's scheduled meetings with analysts and institutional investors.
The disclosure provides the following schedule of meetings:
- Date: June 22, 2026
- Meeting 1: With Motilal Oswal from 12:00 PM to 1:00 PM (IST)
- Meeting 2: With Phillip Capital from 2:00 PM to 3:00 PM (IST)
- Interaction Mode: Physical meeting
- Meeting Type: Single (for both meetings)
The document includes a note stating that this schedule may undergo changes due to exigencies on the part of the meeting participants or the company. It explicitly states that no unpublished price sensitive information (UPSI) is proposed to be shared during these meetings.
The letter is signed by Kaleeswaran Arunachalam, Chief Financial Officer, and carries the company's internal reference number 44/2026-27.
Financial / Operational Impact
No financial or operational impact is disclosed. This is a routine compliance filing to disclose the schedule of investor interactions.